Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference

Review

(12944) Total Article Views

Authors: Steffen Naegel, Mark Obermann

Published Date December 2009 Volume 2010:6(1) Pages 17 - 28

DOI: http://dx.doi.org/10.2147/NDT.S6459

Steffen Naegel, Mark Obermann

Department of Neurology, University of Duisburg-Essen, Hufelandstr. 55, 45122 Essen, Germany

Abstract: Migraine is a very common disorder characterized by the combination of typical headache with associated autonomic symptoms and/or the presence of aura. Considerable advances have been made in recent years to understand the pathophysiology of migraine, which has led to improved treatment options for the acute migraine attack as well as migraine prophylaxis. Unfortunately, preventive treatment is often insufficient to decrease migraine frequency substantially or is not well tolerated. Topiramate is an antipileptic drug with a complex mode of action which has proven its efficacy and safety in the prophylactic treatment of episodic migraine in a number of randomized controlled clinical trials. Topiramate is also effective in treating patients with chronic migraine. It has little pharmacological interaction with other drugs and is generally well tolerated by patients.

Keywords: migraine, antiepileptic drugs, topiramate

Readers of this article also read: